Inventor
HEFFERNAN MICHELE L R
US23 patents
⚠️ This page may combine multiple inventors who share the name “HEFFERNAN MICHELE L R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
10 patentsUS6699866B2Mar 2, 2004
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
SEPRACOR INC17 citations92
US6677332B1Jan 13, 2004
Heterocyclic analgesic compounds and methods of use thereof
SEPRACOR INC22 citations92
US6645980B1Nov 11, 2003
Heterocyclic analgesic compounds and methods of use thereof
SEPRACOR INC46 citations92
US7579370B2Aug 25, 2009
Fused heterocycles
SEPRACOR INC25 citations91
US6635661B2Oct 21, 2003
Heterocyclic analgesic compounds and methods of use thereof
SEPRACOR INC16 citations84
US7884124B2Feb 8, 2011
Fluoro-substituted inhibitors of D-amino acid oxidase
SEPRACOR INC9 citations82
US7129228B2Oct 31, 2006
Heterocyclic analgesic compounds and methods of use thereof
SEPRACOR INC9 citations73
US7087623B2Aug 8, 2006
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
SEPRACOR INC2 citations62
US7902252B2Mar 8, 2011
Inhibitors of D-amino acid oxidase
SEPRACOR INC4 citations61
US7692019B2Apr 6, 2010
Methods for the stereoselective synthesis of substituted piperidines
SEPRACOR INC0 citations51
SUNOVION PHARMACEUTICALS INC
8 patentsUS10196403B2Feb 5, 2019
Compounds and compositions and uses thereof
SUNOVION PHARMACEUTICALS INC8 citations82
US11491133B2Nov 8, 2022
Heteroaryl-isochroman compounds and uses thereof
SUNOVION PHARMACEUTICALS INC2 citations68
US10780074B2Sep 22, 2020
Compounds and uses thereof
SUNOVION PHARMACEUTICALS INC2 citations68
US10640510B2May 5, 2020
Metabotrophic glutamate receptor 5 modulators and methods use thereof
SUNOVION PHARMACEUTICALS INC0 citations50
US10196399B2Feb 5, 2019
Metabotrophic glutamate receptor 5 modulators and methods use thereof
SUNOVION PHARMACEUTICALS INC0 citations50
US10077243B2Sep 18, 2018
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
SUNOVION PHARMACEUTICALS INC0 citations50
US9708331B2Jul 18, 2017
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
SUNOVION PHARMACEUTICALS INC0 citations50
US11186564B2Nov 30, 2021
Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
SUNOVION PHARMACEUTICALS INC0 citations44